Classical vs reverse pharmacology in drug discovery

@article{Takenaka2001ClassicalVR,
  title={Classical vs reverse pharmacology in drug discovery},
  author={Toichi Takenaka},
  journal={BJU International},
  year={2001},
  volume={88}
}
  • T. Takenaka
  • Published 1 September 2001
  • Biology
  • BJU International
The evolution of medical treatments has made remarkable strides thanks to advances in the technology used in drug discovery. In the early days of pharmacology, therapeutic drugs were created from derivatives of medicinal plants. This was the case for aspirin, which was derived from the bark of the willow tree. Some bene®cial drugs have been discovered incidentally during scienti®c research. These desirable accidental discoveries are referred to as drug serendipity. In the 1960s, advances in… 

Molecular Medicine-Prospects and Challenges

The change in approach resulted in impro vement in target innovation, however doesn't impact the rate of NMEs approved, and the challenges offered by molecular medicine and reverse pharmacology for its improvement were discussed.

Discovery and resupply of pharmacologically active plant-derived natural products: A review

Natural Products as a Source for Novel Antibiotics.

  • M. Moloney
  • Biology
    Trends in pharmacological sciences
  • 2016

How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?

This paper briefly presents both classical as well as some more modern, but underutilized, approaches that have been applied outside the field of malaria, and which could be considered in enhancing the potential of natural products to provide or inspire the development of anti-malarial lead compounds.

Translational and Reverse Pharmacology

  • Abialbon Paul
  • Biology, Medicine
    Introduction to Basics of Pharmacology and Toxicology
  • 2019
R reverse pharmacology is the field of drug discovery where the drug targets which might act as critical intervention points in the pathogenic process of diseases are first identified and characterized and fish for an appropriate ligand.

Antibiotic drug discovery

This review focuses on the most significant discovery approaches during the last and present years and comment on the challenges facing the community in the coming years.

Natural Product-Based Drug Discovery in Africa: The Need for Integration into Modern Drug Discovery Paradigms

In this chapter, some of the components that could underpin a complete reevaluation of how natural product drug discovery is conducted on the continent are described.

Phytochemicals as Sources of Drugs

This chapter presents an overview of the usefulness of medicinal plants as sources of drugs, the drug discovery process, the efficacy and safety of phytochemicals, current uses, advances in screening tools, problems and the way forward.
...

References

SHOWING 1-9 OF 9 REFERENCES

New sulfamoylphenethylamines, potent α1‐adrenoceptor antagonists

Among the desoxy derivatives, YM-12617 was more potent than prazosin in blocking alpha 1-adrenoceptors in anaesthetized rats and in reducing blood pressure, total peripheral resistance and left ventricular work in anasthetized dogs.

New sulfamoylphenethylamines, potent alpha 1-adrenoceptor antagonists.

Among the desoxy derivatives, YM-12617 was more potent than prazosin in blocking alpha 1-adrenoceptors in anaesthetized rats and in reducing blood pressure, total peripheral resistance and left ventricular work in anasthetized dogs.

Ethanol‐ and isoprenaline‐induced responses in pig parenchymal lung tissue

Single low concentrations of ethanol, which can occur in‐vivo in man, caused increases in the relaxant potency of isoprenaline in pig lung strips, although the sizes of these increases varied widely.

Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck.

It is suggested that certain instances of acute retention of urine in prostatic patients are due to over-stimulation of the alpha-adrenergic receptors, particularly those in the prostatic capsule, as well as the distribution of the cholinergic receptors in the tissues examined.

Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs.

The results suggest that the alpha 1-adrenoceptor mediates the increase in IUP as well as DBP in anaesthetized dogs, and thatalpha 1- adrenoceptors in the urethra and arteries show a stereochemical preference for R(-)-YM.

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Tamsulosin 0.4 mg once daily is safe, well-tolerated and improves both the symptoms and urinary flow rate in patients with benign prostatic obstruction (symptomatic BPH).

a 1 A - adrenoceptor antagonist . A meta - analysis of two randomized , placebo - controlled , multicentre studies in patients with benign prostatic obstruction ( symptomatic BPH )

    Facing the Future in the Prostatic a1 Receptors

    • The Netherlands: SIU, Academic Journals,
    • 1996